Juli Miller | Senior Director, IR |
Adrian Rawcliffe | CEO |
Elliot Norry | Senior VP and Chief Medical Officer |
Helen Tayton-Martin | Co-Founder and Chief Business Officer |
Karen Miller | SVP, Pipeline Research |
John Lunger | Chief Patient Supply Officer |
Marc Frahm | Cowen and Company |
Nick Abbott | Wells Fargo |
Tony Butler | Roth Capital |
Jonathan Chang | SVB Leerink |
Mara Goldstein | Mizuho |
Ladies and gentlemen, thank you for standing by and welcome to Q1 2021 Adaptimmune Earnings Conference Call. At this time all participants are in a listen-only mode. [Operator Instructions] I will now like to hand the conference over to your speaker for today, Juli Miller.
You may begin.
Good morning and welcome to Adaptimmune's conference call to discuss our first quarter 2021 financial results and business update.